to assess the antiarrhythmic efficacy of intravenous propafenone , 20 patients with inducible sustained supraventricular tachycardia received propafenone , 2 mg/kg body weight , or placebo in a double-blind , randomized , crossover study .
C0039240
supraventricular tachycardia
C0033429
propafenone